Cingulate Announces Positive Top-Line Results from Fed/Fast Study of Lead Asset…
<!-- Name:DistributionId Value:8755907 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
Topline
ETMarkets Management Talk: Meghmani Finechem likely to end FY23 with topline of Rs…
Having reported strong numbers for the quarter ended December, is confident of sustaining the show in the current quarter as well and meeting its guidance for FY23. “We believe that we will…
Ocuphire Announces Topline Results from ZETA-1 Phase 2 Trial of Oral APX3330 in…
Oral APX3330 Achieved Statistical Significance on a Key Pre-specified Secondary Endpoint of Preventing Clinically Meaningful Progression of Diabetic Retinopathy (DR) after 24 Weeks of…
XORTX Announces Positive Topline Results from XRX-OXY-101 Clinical Trial
CALGARY, Alberta, Jan. 19, 2023 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical…
IT biggies post 14-20% topline growth in Q3 as caution; optimism marks mixed…
New Delhi: India's IT services heavyweights delivered between 14-20 per cent on-year growth in topline for December quarter, as they raised guard on global uncertainties and choppy…
Ocugen Announces Positive Top-Line Data for COVID-19 Vaccine Candidate COVAXIN™…
Study met both co-primary endpoints with robust immune responses COVAXIN™ was found to be well-tolerated in vaccine-naïve individuals and in individuals previously vaccinated with mRNA…
Phathom Pharmaceuticals Announces Positive Topline Results from Phase 3…
Both vonoprazan 10 mg and 20 mg doses met the primary endpoint and showed highly statistically significant greater percentage of 24-hour heartburn free days as compared to placebo…
Vera Therapeutics Announces Positive Topline Results of Phase 2b ORIGIN Clinical…
Atacicept met primary endpoint at 24 weeks, and also achieved statistical significance in the 150 mg dose group with a 33% mean reduction in proteinuria from baseline, with available data…
Applied Molecular Transport Announces Top-line Phase 2 Results from LOMBARD…
– Similar clinical remission rates observed in patients receiving AMT-101 monotherapy compared to placebo at week 12 – AMT-101 was well-tolerated – Planned Phase 1b trial for the…
Acasti Pharma Announces Preliminary Topline Results Met All Primary Outcome Measures…
LAVAL, Québec, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three…